0 the state of having abnormally low levels of neutrophils (= disease-fighting white blood cells) in the blood:
Neutropenia is frequently associated with the use of chemotherapeutic drugs to treat cancer.
No febrile neutropenia or drugrelated deaths have occurred to date.
The anaemia, neutropenia and thrombocytopenia may occur either singly or in combination and there is, by definition, no underlying systemic illness to account for them.
After critical appraisal of these studies, we considered 2,116 as the most reliable estimate for the cost of a case of neutropenia.
These patients had many risk factors including hepatic failure, insulin-dependent diabetes mellitus, metastatic and non-metastatic cancer, neutropenia and renal failure.
The latter were confined to neutropenia (2) and anemia (1).
Through consultation with five rheumatologists and gastroenterologists we concluded that the clinical path followed in the treatment of neutropenia depends on its severity.
Using granulocyte colony-stimulating factor for neutropenia during neonatal sepsis.
The causal relationship between severe neutropenia and lethality is also rather weak.
